MIRICOR (HKEX: 01827) has announced its financial results for the fiscal year ended March 31, 2026. The company recorded total revenue of approximately HK$362 million, which represents a decrease of 10.11% compared to the previous year.

Despite the drop in overall revenue, the profit attributable to shareholders showed resilience, rising by 5.7% to around HK$11.2 million. Earnings per share for the period stood at 2.81 HK cents.

The board has proposed a final dividend of 10 HK cents per ordinary share.

Operational Performance and Market Conditions

During the reported fiscal year, the group operated five treatment centers. The company noted that revenue from its medical aesthetics services remained relatively stable, supported by its established reputation, brand recognition, and consistently high-quality service standards.

Concurrently, the group maintained four retail outlets in premier shopping centers in Hong Kong and sold skincare products in both mainland China and Hong Kong through various channels, including online platforms.

The performance of the skincare retail segment was impacted by a weak retail market and subdued consumer sentiment, leading to a period of adjustment in revenue from this business line. The company stated that while total group revenue experienced a decline, its overall operations maintained strong resilience.